BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
MYC
,
glucose metabolic process
,
Diabetes mellitus
,
Embryo
,
Rosiglitazone
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
g2 phase of mitotic cell cycle
Summary
General Info
Curated Studies
Most Correlated Studies
Prostate adenocarcinoma LNCaP cells treated with dihydrotestosterone in different cell cycle phases
Irradiated human fibroblasts compared to cells at each phase of cell cycle
Retinal pigment epithelial RPE-1 cells; role of translational repression in M-phase entry
Cervical cancer HeLa cells in G1 or G2-M phase treated with WNT3a or DKK1
Embryonic stem cell line H9 expressing PAX6 after all-trans retinoic acid treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
MAPK inactivation is required for the G2 to M-phase transition of the first mitotic cell cycle.
Distinct modes of cyclin E/cdc2c kinase regulation and S-phase control in mitotic and endoreduplicat…
Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic ce…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors
ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Can…
Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors
Phase III Study of Surufatinib in Treating Advanced Pancreatic Neuroendocrine Tumors
Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ